ArticleFrontiers in pediatrics2024

Caplacizumab as an add-on therapy in a 7-year-old girl with exacerbated immune-mediated thrombotic thrombocytopenic purpura, a case report and literature review.

Lara Chavaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.